M. J. Gallimore - Concepedia

Author

M. J. Gallimore

Also Known As

D. W. Jones, M Gallimore, M J Gallimore, M. Gallimore, M. J Gallimore, M. J. Gallimore, M. Winter, M.J Gallimore, M.J. GALLIMORE, M.J. Gallimore

113

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Kent and Canterbury Hospital University College London University of Kent University of Tübingen Pfizer (United Kingdom)

About

M. J. Gallimore is an author at Kent and Canterbury Hospital specializing in medicine, pharmacology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	35	985
2	Biochemistry	11	13	356
3	Natural Sciences	8	8	201
4	Health Sciences	7	7	187
5	Public Health	1	1	24

M. J. Gallimore

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation. Richard J. Grand, Peter Grabham, M. J. Gallimore, The EMBO Journal BiochemistryNatural SciencesMedicineCytoskeletonSerine Proteases	1989	73
Reduced factor XII levels in patients with the antiphospholipid syndrome are associated with antibodies to factor XII D. W. Jones, M. J. Gallimore, Ian Mackie, British Journal of Haematology	2000	72
Antibodies to Factor XII Associated with Lupus Anticoagulant M. J. Gallimore, S. L. Harris, M. Winter, Thrombosis and Haemostasis Autoimmune DiseaseLupusMedicineImmunologyHematology	1999	52
Aprotinin in cardiopulmonary bypass- effects on the Hageman factor (FXII)-Kallikrein system and blood loss G. Fuhrer, M. J. Gallimore, W. Heller, Blood Coagulation & Fibrinolysis	1992	49
The purification of a human plasma kallikrein with weak plasminogen activator activity M. J. Gallimore, E. Fareid, Helge Stormorken Thrombosis Research BiochemistryMedicineBioanalysisFibrinolysisClinical Chemistry	1978	48
Antibodies to factor XII and recurrent fetal loss in patients with the anti‐phospholipid syndrome D. W. Jones, I. J. Mackie, M. J. Gallimore, British Journal of Haematology	2001	47
Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis M. J. Gallimore, S. L. Harris, D. W. Jones, Thrombosis Research ThrombosisVenous ThrombosisNormal Blood DonorsCardiovascular DiseasePlasma Levels	2004	45
The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement H.P. Wendel, W. Heller, M. J. Gallimore, Blood Coagulation & Fibrinolysis Heart FailureCardiac AnaesthesiaWhole BloodPharmacotherapySurgery	1993	45
Thrombin generation: a comparison of assays using platelet‐poor and ‐rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism Kerry A. Tappenden, M. J. Gallimore, Gillian Evans, British Journal of Haematology Plasma AssaysWhole Blood SamplesThrombosisVenous ThrombosisPlatelet Concentrates	2007	42
The Measurement of Fibrinolysis in the Rat M. J. Gallimore, H. M. Tyler, J. T. B. Shaw Thrombosis and Haemostasis Summary MethodsFibrinolytic ActivityPharmacotherapyThrombosisLimited Fibrinolysis	1971	42

Page 1